Original-Research: Gallmetzer HealthCare SpA (von NuWays AG): BUY - T-Online

Direct Source Verification: This story is aggregated from t-online (t-online.de). Full reporting rights and copyright belong to the primary publisher.
The issuer is solely responsible for the content of this research. The

The issuer is solely responsible for the content of this research. The

invitation to conclude certain stock exchange transactions.

margin expansion. The company is a vertically integrated dental healthcare

sustainability-focused premium oral care.

Gerhò as resilient foundation and route to market. Italy's second-largest

record is supplying a large customer base of ~55,850 customers. Its strong

underpin a resilient, cash-generative business model. A gradually rising

private-label share supports the long-term margin potential.

Intermedical Pharma to enter the local anesthetics market. As one in five

allows GHC to capture an attractive part of the value chain. With

Intermedical Pharma into a growth and margin engine for GHC.

and margin potential. The brand (70% stake) differs from peers through its

a more hygienic sustainable material. Promis is rapidly expanding its global

presence, for the most part through distribution partnerships. A notable

exception was the US market entry in April 25 through Promis USA.

line Promis Kids in FY26, creating further growth support.

We expect organic revenue to grow at a 7.7% CAGR (eNuW) through FY30e,

alongside 5.2pp of EBITDA margin expansion to 6.9% (eNuW), as the group

increasingly captures value further up the dental product value chain. In

Two complementary value-creation layers to GHC's investment case. Firstly,

pricing position, customer retention, organic growth and margins. Secondly,

customer base. Key catalysts to accelerating the earnings trajectory are

European countries through a step-up process.

We INITIATE GHC with BUY at a PT of EUR 4.40 per share, based on DCF.

https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&u=e75885eb61b8417641f8e48092ba6795

LinkedIn: https://www.linkedin.com/company/nuwaysag

analysierten Unternehmen befindet sich in der vollständigen Analyse.

Financial/Corporate News and Press Releases.

https://eqs-news.com/?origin_id=f71ae90a-b582-11f1-9d22-0a083a71a9ab&lang=en

Die Ströer Digital Publishing GmbH übernimmt keine Gewähr für die Richtigkeit, Genauigkeit und Vollständigkeit der Angaben. Verzögerung der Kursdaten: Deutsche Börse 15 Min., Nasdaq und NYSE 20 Min.

Original Source
https://www.t-online.de/finanzen/boerse/ticker/original-research-gallmetzer-healthcare-spa-von-nuways-ag-buy/0DBA6A009C4636C7/
Visit t-online ↗
SHARE STORY:
𝕏 f in

Related Coverage in Health